About Critical Diagnostics
Critical Diagnostics is a company based in San Diego (United States) founded in 2004.. Critical Diagnostics has raised $11.07 million across 3 funding rounds. The company has 1 employees as of December 31, 2021. Critical Diagnostics operates in a competitive market with competitors including SphingoTec, BG Medicine, Pronota, Upstream Medical Technologies and CorPatch, among others.
- Headquarter San Diego, United States
- Employees 1 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Critical Care Diagnostics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.07 M (USD)
in 3 rounds
-
Latest Funding Round
$8.5 M (USD), Series A
Jan 03, 2018
-
Investors
-
Employee Count
1
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Critical Diagnostics
Critical Diagnostics has successfully raised a total of $11.07M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $8.5 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $8.5M
- First Round First Round
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Series A - Critical Diagnostics | Valuation |
investors |
|
| Mar, 2013 | Amount | Series A - Critical Diagnostics | Valuation |
investors |
|
| Dec, 2012 | Amount | Seed - Critical Diagnostics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Critical Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Critical Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Critical Diagnostics Comparisons
Competitors of Critical Diagnostics
Critical Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SphingoTec, BG Medicine, Pronota, Upstream Medical Technologies and CorPatch, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed.
|
|
| domain | founded_year | HQ Location |
Diagnostic tests for cardiovascular disorders are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Diagnostics for heart failure, pre-eclampsia, and sepsis are provided.
|
|
| domain | founded_year | HQ Location |
Patented cardiac biomarkers are developed for heart disease diagnostics.
|
|
| domain | founded_year | HQ Location |
Offers CPR feedback devices and apps for effective training and assistance during emergencies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Critical Diagnostics
Frequently Asked Questions about Critical Diagnostics
When was Critical Diagnostics founded?
Critical Diagnostics was founded in 2004 and raised its 1st funding round 8 years after it was founded.
Where is Critical Diagnostics located?
Critical Diagnostics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Critical Diagnostics a funded company?
Critical Diagnostics is a funded company, having raised a total of $11.07M across 3 funding rounds to date.
How many employees does Critical Diagnostics have?
As of Dec 31, 2021, the latest employee count at Critical Diagnostics is 1.
What does Critical Diagnostics do?
Critical Diagnostics is focused on the development of novel biomarkers-based tests in cardiovascular disease diagnostics. Its lead product, the Presage ST2 Assay, is an ELISA assay that measures soluble ST2 in the patients blood to arrive at a prognosis for heart failure patients. The company has received FDA clearance and is CE marked in Europe for Presage. In addition, the company also markets the ASPECTLF ST2 test, ASPECT READER and associated ASPECT-PLUS tests, all based on ST2 assays.
Who are the top competitors of Critical Diagnostics?
Critical Diagnostics's top competitors include SphingoTec, BG Medicine and Upstream Medical Technologies.